logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Large Cap

Ajanta Pharma Share Price

Ajanta Pharma Ltd.

₹2,828.90

23.80(0.85%)

Invest in AJANTPHARM with up to 2.86x margin.

Trade with MTF
1st Apr 2026 | 1:14 PM
NSE : AJANTPHARM
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Ajanta Pharma Performance

Price Movement

₹2828.90

₹2794.80

₹2880.00

↘ Today's Low↗ Today's High

1 Year Performance

₹2828.90

₹2327.30

₹3228.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,880.00
Low₹2,794.80
Open at₹2,849.90
Prev Close₹2,805.10
Volumes45.42 K
Avg Price₹2,844.18
Lower Circuit₹2,244.10
Upper Circuit₹3,366.10

Historical Performance

3M High₹3,228.00
3M Low₹2,654.50
1 Yr High₹3,228.00
1 Yr Low₹2,327.30
3 Yr High₹3,485.00
3 Yr Low₹1,190.15
5 Yr High₹3,485.00
5 Yr Low₹1,061.77

Ajanta Pharma Fundamentals

Market Cap
High in industry
35,039.10 Cr.
PE Ratio (TTM)
Above industry Median
34.50
Dividend Yield
Above industry Median
1
Net Profit TTM
13.0% incr over last year
1,014.56
Net Profit Growth
13.0% incr over last year
1,014.56
PEG Ratio
High in industry
2.70
ROE
6.2% incr over last year
24.28
Operating Revenue TTM
5,201.63
Operating Revenue Growth
14.8% incr over last year
Book Value
High in industry
7.60
MFI
MFI is mid-range
54.28
RSI
RSI is mid-range
41.39
EPS (TTM)
73.56
Debt to Equity
0
Face Value
2
Operating Profit Margin Qtr.
26.56
Operating Profit Qtr.
382.24
Net Profit Qtr.
273.77
Operating Revenue Qtr.
1,374.84
PB Ratio
7.60

Ajanta Pharma Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue1,206.591,220.241,208.561,013.941,101.92
Operating Expense865.64930.65879.16764.29765.59
Operating Profit340.95289.59329.40249.65336.33
Depreciation42.3841.9240.3138.7634.93
Interest1.870.730.730.672.48
Tax77.4272.4474.0234.7279.70
Net Profit245.04249.53254.97193.43252.45

Ajanta Pharma Technicals

Ajanta Pharma Ltd. EMA & SMA

₹2828.90

21.00 (0.75%)

↗ Bullish Moving Average

5

↘ Bearish Moving Average

11

Day EMA5 ₹2843.4
Day EMA10 ₹2885.2
Day EMA12 ₹2896
Day EMA20 ₹2916
Day EMA26 ₹2916.9
Day EMA50 ₹2882.2
Day EMA100 ₹2801.1
Day EMA200 ₹2727

Ajanta Pharma Support and Resistance

Resistance

First Resistance₹2836.97
Second Resistance₹2868.83
Third Resistance₹2917.77

Support

First Support₹2756.17
Second Support₹2707.23
Third Support₹2675.37

Technical Indicators

Day RSI41.39
Day MFI54.28
Day ADX17.51
Day Commodity Channel Index-157.10
William-86.50
Day MACD-20.92
Day MACD Signal Line7.49
Day ATR105.05
Day ROC12512.68
Day ROC21-7.16

Ajanta Pharma Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter66.366.366.366.366.266.2
FII9.19.38.98.98.58
DII17.11717.517.517.918.6
Public7.57.47.47.47.37.2

Ajanta Pharma Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day1.08 L1.59 L68.22%
Week62.99 K1.05 L60.06%
1 Month87.29 K1.44 L60.64%
6 Month72.55 K1.27 L57.28%

Ajanta Pharma SWOT Analysis

Strengths15
Weakness9
Opportunity3
Threats1

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Rising Net Cash Flow and Cash from Operating activity

Dividend yield greater than sector dividend yield

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 3 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Ajanta Pharma Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
10 Nov, 202528INTERIM10 Nov, 2025Equity Share
06 Nov, 202428INTERIM06 Nov, 2024Equity Share
08 Feb, 202426INTERIM08 Feb, 2024Equity Share
04 Aug, 202310INTERIM04 Aug, 2023Equity Share
04 Aug, 202315SPECIAL04 Aug, 2023Equity Share
11 Nov, 20227INTERIM14 Nov, 2022Equity Share
09 Nov, 20219.5INTERIM10 Nov, 2021Equity Share
12 Nov, 20209.5INTERIM13 Nov, 2020Equity Share
15 Nov, 201913INTERIM18 Nov, 2019Equity Share
09 Nov, 20189INTERIM12 Nov, 2018Equity Share

Ajanta Pharma Stock Comparison

Financials
Anthem Biosciences Ltd.
Sai Life Science Ltd.
Emcure Pharmaceuticals Ltd.
Mankind Pharma Ltd.
Gland Pharma Ltd.
Laurus Labs Ltd.
Price (₹)₹673.60₹967.85₹1,596.80₹1,999.70₹1,725.10₹1,035.50
% Change2.64%-0.43%0.08%-0.30%1.71%4.31%
Revenue TTM (₹ Cr)₹1,996.59₹2,169.86₹8,850.08₹13,914.08₹6,112.77₹6,721.63
Net Profit TTM (₹ Cr)₹484.66₹332.94₹869.92₹1,779.35₹847.18₹843.32
PE TTM76.1061.8034.8046.5033.0063.50
1 Year Return15.1327.7548.78-17.286.5161.84
ROCE26.8812.5120.8013.2711.4311.82

Similar Stocks

ALKEM

Alkem Laboratories Ltd.

₹ 5264.00

-0.66%

BIOCON

Biocon Ltd.

₹ 369.25

+2.31%

DIVISLAB

Divi's Laboratories Ltd.

₹ 5912.50

-0.58%

ZYDUSLIFE

Zydus Lifesciences Ltd.

₹ 873.60

+0.28%

GLENMARK

Glenmark Pharmaceuticals Ltd.

₹ 2119.50

-0.57%

AUROPHARMA

Aurobindo Pharma Ltd.

₹ 1344.40

+3.07%

SUNPHARMA

Sun Pharmaceutical Industries Ltd.

₹ 1729.90

-1.55%

IPCALAB

Ipca Laboratories Ltd.

₹ 1561.90

-2.45%

JBCHEPHARM

J B Chemicals & Pharmaceuticals Ltd.

₹ 2009.60

-2.65%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 7867.00

+1.31%

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd.

₹ 2335.60

+2.30%

PFIZER

Pfizer Ltd.

₹ 4833.30

+2.39%

ABBOTINDIA

Abbott India Ltd.

₹ 26405.00

+1.89%

TORNTPHARM

Torrent Pharmaceuticals Ltd.

₹ 4153.40

-1.58%

LUPIN

Lupin Ltd.

₹ 2281.20

-1.41%

DRREDDY

Dr. Reddy's Laboratories Ltd.

₹ 1228.00

-2.14%

CIPLA

Cipla Ltd.

₹ 1201.60

-1.85%

FAQ's on AJANTPHARM

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy